Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...
NewsNation on MSN9h
Could Trump’s tariffs cause drug shortages, price increases?
How could Trump’s tariffs affect prices, availability at the pharmacy? “That additional 10 percent tariff is going to have a fairly significant impact on the cost of goods for ...
Sino Biopharmaceutical, One of the Largest Chinese Drugmakers, Is in the Transformation Stage
Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...
Devdiscourse13h
Hypera's Ambitious Entry into the Semaglutide Market: A New Dawn for Generics in Brazil
Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...
Gyre: Intriguing Upcoming Data Catalyst, But I'm Still On Sidelines
Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...
Newspoint on MSN3h
Weight loss drug launched in India, will reduce sagging fat, weight will reduce up to 21 kg, know the price and where to get it
In India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar ...
Walgreens Boots Alliance, Inc. (NASDAQ:WBA): Business Under Pressure as Legal Risks Mount
We came across a bearish thesis on Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on ValueInvestorsClub by quads1025. In this ...
Corcept Therapeutics Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CORT
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept ...
Unichem Labs up 5% on completing capacity expansion of plant at Pithampur
"We would like to inform that the Company has completed the capacity expansion (Phase I) of the API plant at Pithampur," the ...
Woolworths, Coles drives ASX higher
A rally in Woolworths and Coles shares on Friday helped the ASX finish higher on Friday, helping to lift the ASX to its best weekly gain in 2025.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Viatris Inc.(NASDAQ:VTRS) resulting from allegations that ...